Tech Company Inital Public Offerings

Mirum Pharmaceuticals IPO

Mirum Pharmaceuticals, based in Foster City, had an IPO event on 7/17/2019.

Transaction Overview

Announced On
Transaction Type
Proceeds Purpose
Per the firm's latest filing, it plans to use the net proceeds from the IPO and cash on hand as follows: approximately $95.0 million to $105.0 million to further the clinical development of maralixibat, including our planned Phase 3 clinical trials in PFIC and ALGS and our anticipated clinical program in BA; approximately $30.0 million to $40.0 million to further the clinical development of volixibat, including our planned Phase 2 clinical trials in ICP and PSC; and the remainder for other ongoing research and development activities, and for general corporate purposes, including working capital, operating expenses and capital expenditures.

Company Information

Company Status
Mailing Address
950 Tower Ln. 1050
Foster City, CA 94404
Email Address
Mirum Pharmaceuticals Inc. (Nasdaq: MIRM) is a therapeutics company developing a novel approach for treating cholestatic liver diseases, with an immediate focus on rare pediatric conditions.
Mirum Pharmaceuticals LinkedIn Company Profile
Social Media
Mirum Pharmaceuticals Company Twitter Account
Company News
Mirum Pharmaceuticals News
Mirum Pharmaceuticals on Facebook
Mirum Pharmaceuticals on YouTube

Management Team

Email & Social
Michael Grey
  Michael Grey LinkedIn Profile  Michael Grey Twitter Account  Michael Grey News  Michael Grey on Facebook
Chief Executive Officer
Chris Peetz
  Chris Peetz LinkedIn Profile  Chris Peetz Twitter Account  Chris Peetz News  Chris Peetz on Facebook
Chief Financial Officer
Ian Clements
  Ian Clements LinkedIn Profile  Ian Clements Twitter Account  Ian Clements News  Ian Clements on Facebook
Chief Medical Officer
Ed Tucker
  Ed Tucker LinkedIn Profile  Ed Tucker Twitter Account  Ed Tucker News  Ed Tucker on Facebook
Chief Operating Officer
Peter Radovich
  Peter Radovich LinkedIn Profile  Peter Radovich Twitter Account  Peter Radovich News  Peter Radovich on Facebook
VP - Bus. Development
Lara Longpre
  Lara Longpre LinkedIn Profile  Lara Longpre Twitter Account  Lara Longpre News  Lara Longpre on Facebook



Browse more venture capital transactions:

Prev: 7/17/2019: Tego venture capital transaction
Next: 7/17/2019: Curve venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary